Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Jan-Mar;39(1):27-32.
doi: 10.4103/iju.iju_179_21. Epub 2022 Dec 29.

Perioperative, oncological, and survival outcomes of robotic radical cystectomy with urinary diversion in females: A single-center retrospective observational study

Affiliations

Perioperative, oncological, and survival outcomes of robotic radical cystectomy with urinary diversion in females: A single-center retrospective observational study

Varun V Agarwal et al. Indian J Urol. 2023 Jan-Mar.

Abstract

Introduction: Robot-assisted radical cystectomy (RARC) is a standrad approach for surgical management of bladder cancer. Currently, most literature on RARC is in men, possibly due to the higher incidence of bladder cancer in males. We reviewed the perioperative, oncological and survival outcomes in 41 women who underwent RARC by a single surgeon at a tertiary health-care center.

Methods: Out of 225 RARC and urinary diversion procedures performed from 2012 to 2020, a retrospective analysis of 41 women was performed. Baseline demographic and perioperative details, oncological data, and survival were recorded and analyzed. Kaplan-Meir analysis was done for survival outcomes and prognostic factors were assessed by log rank test.

Results: Thirty-eight patients underwent intracorporeal urinary diversion, while three underwent extracorporeal diversion. One patient underwent organ preserving cystectomy. Clavien-Dindo 30-day postoperative complications were Grade I in 8 (19.5%), Grade II in 4 (9.8%), and Grade IIIa in 3 (7.3%) patients with no mortality. During the median follow-up of 34 months (range: 6-87 months), 7 patients died of disease recurrence. Five-year survival was 74% (95% confidence interval [CI]: 59-82) and 35% (95% CI: 10-91) in transitional cell carcinoma (TCC) and non-TCC group, respectively, with P = 0.04. There was no mortality in Stages 0 and 1 disease. Five-year survival was 78% in Stage 2 and 41% in Stage 3 and 4.

Conclusion: Our study demonstrates acceptable clinical, perioperative, and oncological outcomes of robotic radical cystectomy in females, thus highlighting its safety and feasibility.

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest: There are no conflicts of interest.

Figures

Figure 1
Figure 1
Estimated probability of overall survival with Kaplan–Meier analysis in female patients treated with robot-assisted radical cystectomy and urinary diversion
Figure 2
Figure 2
Estimated probability of overall survival with Kaplan–Meier analysis in female patients treated with robot-assisted radical cystectomy and urinary diversion. Stratification based on the histological variant of the disease into TCC and non-TCC. TCC = Transitional cell carcinoma
Figure 3
Figure 3
Estimated probability of overall survival with Kaplan–Meier analysis in female patients treated with robot-assisted radical cystectomy and urinary diversion. Stratification based on the stage of the disease

References

    1. Guru KA, Kim HL, Piacente PM, Mohler JL. Robot-assisted radical cystectomy and pelvic lymph node dissection: Initial experience at Roswell Park Cancer Institute. Urology. 2007;69:469–74. - PubMed
    1. Menon M, Hemal AK, Tewari A, Shrivastava A, Shoma AM, El-Tabey NA, et al. Nerve-sparing robot-assisted radical cystoprostatectomy and urinary diversion. BJU Int. 2003;92:232–6. - PubMed
    1. Pruthi RS, Wallen EM. Robotic assisted laparoscopic radical cystoprostatectomy: Operative and pathological outcomes. J Urol. 2007;178:814–8. - PubMed
    1. Hall MC, Chang SS, Dalbagni G, Pruthi RS, Seigne JD, Skinner EC, et al. Guideline for the management of nonmuscle invasive bladder cancer (stages Ta, T1, and Tis): 2007 update. J Urol. 2007;178:2314–30. - PubMed
    1. Weissbart SJ, Smith AL. Hysterectomy in the urologist's practice. Curr Urol Rep. 2017;18:4. - PubMed